ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751152 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751152; 2) Community: the network communities that were significantly associated with the response to NSC 751152; 3) Molecule: the relationships between components within communities and NSC 751152; 4) MDR: the compounds that were significantly associated with the NSC 751152.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0385613993886001 0.25769628
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0385613993886001 0.34333643
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0385613993886001 0.64745439
NSC 328477 3'-Chloro-3-nitro-o-salicylotoluidide 0.0385613993886001 0.21162909
NSC 339137 PHYSALOLACTONE 0.0385613993886001 0.38685007
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0385613993886001 0.6440854
NSC 39215 Null 0.0385613993886001 0.60854256
NSC 42972 Null 0.0385613993886001 0.71850963
NSC 606497 Camptothecin Derivative 0.0385613993886001 0.075620413
NSC 622696 Thioperoxydicarbonic diamide, tetramethyl- 0.0385613993886001 0.43473178
Total:93  Current:65    [First] [Prev] [Next] [Last]